many articles surfacing on tamiflu resistance, page-11

Miso

You are correct in everything you say. I have followed BTA for many years. We post on the same forums from time to time.

I repeat that MGMT is no risk to relenza royalty stream. Thank goodness for that.

I predicted Events would overtake both GSK and BTA. This is happening. GSK in particular will be forced into IV Zan. GSK has been forced into making a new delivery method. GSK has been forced to increase production. GSK will be forced into a lot more actions concerning relenza.

I re-entered based on exactly what I said.

Both GSK and BTA cannot harm the relenza royalty stream.
If they could I would never of bought back in.

When this dollar amount gets to a obscene level. Shareholders will rebel on mass. To go over and over on their lack of mgmt is getting just plain boring and obsessive. I KNOW, WE ALL KNOW.

PS You have all my votes to get rid of them.